Peptide Therapeutics Market 2020: America, EMEA & APAC Regions Analyzed Report

The analysts forecast global peptide therapeutics market to grow at a CAGR of 7.92% during the period 2016-2020.

Peptides are organic compounds that are composed of amino acids linked chemically by peptide bonds. They are the most potent biologically active substances found in nature and are used to trigger, control, and maintain an individual’s physiological processes. However, using peptides as therapeutic agents was always difficult as they are quite instable and cannot pass through cellular membranes. They also require a specific technology to tackle extensive and challenging steps in their synthesis. Over 80 peptides are marketed by companies that explore the probabilities of designing and engineering peptides that can overcome their natural limits. They can be introduced as a treatment for chronic indications.

Covered in this report

This report covers the present scenario and the growth prospects of the global peptide therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of prescription and generic drugs used to treat diseases.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Peptide Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

For more Information on the report, inquire at

Key vendors

  • Eli Lilly
  • Novo Nordisk
  • Sanofi
  • Takeda Pharmaceutical
  • Teva Pharmaceuticals

Other prominent vendors

  • AbbVie
  • Advanced Accelerator Applications
  • Akashi Therapeutics
  • Amgen
  • Anthera Pharmaceuticals
  • AstraZeneca
  • Bachem
  • Bristol-Myers Squibb
  • Cardiorentis
  • Corden Pharma International
  • Debiopharm
  • Derma Sciences
  • GlaxoSmithKline
  • Hanmi Pharmaceutical
  • Insmed
  • Ipsen
  • Johnson & Johnson
  • Lonza
  • Mallinckrodt
  • MolMed
  • Merck
  • Novartis
  • Nymox Pharmaceutical
  • Par Pharmaceuticals
  • PeptiDream
  • Polypeptide Group
  • Radius Health
  • Repligen
  • Roche
  • SciClone
  • Shire
  • The Medicines Company
  • Transition Therapeutics
  • X-Gen Pharmaceuticals
  • Zealand Pharma
  • Zydus Cadila

Purchase a copy of the report at

Market driver

  • Increase in patient population

Market challenge

  • High cost of therapy

Market trend

  • Shifting focus toward untapped markets

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Inquire for Discount at

About US:  is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.